Weiss Asset Management LP Adverum Biotechnologies, Inc. Transaction History

Weiss Asset Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$3.03 - $6.02 $71,277 - $141,614	-23,524 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.87 - $5.92 $28,470 - $58,726	9,920 Added 72.92%	23,524 $74,000
Q3 2018 Nov 13, 2018	BUY	$4.5 - $7.6 $10,800 - $18,240	2,400 Added 21.42%	13,604 $82,000
Q2 2018 Aug 13, 2018	SELL	$5.3 - $6.9 $17,977 - $23,404	-3,392 Reduced 23.24%	11,204 $59,000
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $53,275 - $116,038	14,596 New	14,596 $85,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Weiss Asset Management LP with notifications on news.